missing translation for 'onlineSavingsMsg'
Learn More
Learn More
EGFR Monoclonal Antibody (OTI3D7), TrueMAB™, OriGene
Mouse Monoclonal Antibody
Brand: Origene Technologies TA802042S
This item is not returnable.
View return policy
Description
EGFR Monoclonal antibody specifically detects EGFR in Human samples. It is validated for Western BlotSpecifications
| EGFR | |
| Monoclonal | |
| 1 mg/mL | |
| PBS with 1% BSA, 50% glycerol and 0.02% sodium azide | |
| P00533 | |
| Mouse | |
| Affinity chromatography | |
| RUO | |
| 1956 | |
| -20° C, Avoid Freeze/Thaw Cycles | |
| IgG1 |
| Western Blot | |
| OTI3D7 | |
| Unconjugated | |
| EGFR | |
| 2.7.10.1; 9030024J15Rik; AI552599; avian erythroblastic leukemia viral (v-erbB) oncogene homolog; avian erythroblastic leukemia viral (v-erb-b) oncogene homolog; cell growth inhibiting protein 40; cell proliferation-inducing protein 61; EC 2.7.10.1; egf receptor; Egfr; EGFR-related peptide; epidermal growth factor receptor; epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian); Epidermal growth factor receptor formerly avian erythroblastic leukemia viral (v-erbB) oncogene homolog (Erbb1); epidermal growth factor receptor, formerly avian erythroblastic leukemia viral (v-erbB) oncogene homolog (Erbb1); ERBB; ERBB1; ErbB-1; erb-b2 receptor tyrosine kinase 1; Errb1; Errp; HER1; kinase EGFR; mENA; NISBD2; Oncogene ERBB; PIG61; Proto-oncogene c-ErbB-1; receptor tyrosine-protein kinase erbB-1; Urogastrone; wa2; wa-2; Wa5; waved 2 | |
| Human recombinant protein fragment corresponding to amino acids 900-1210 of human EGFR produced in E.coli. | |
| 30 μL | |
| Primary | |
| Human | |
| Liquid |
Product Content Correction
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction